The purpose of this article is to review the experiences of family planning clinic providers in making Norplant available to adolescents.
We look specifically at the proportions of women receiving the implant from these providers who are teenagers, the policies adopted regarding implant education and whether or not parental consent is required for minors.
Pricing policies and the implications of high method cost for teenagers are discussed.
Finally, some of the policies adopted by state agencies related to adolescent use of the implant are reviewed.
Over one-quarter of all contraceptive implants inserted by family planning agencies were provided to teenagers.
Teenagers were routinely informed about the implant in about 85% of those clinics offering implant services.
Few state agencies notify women about the implant.
Twenty-three percent of all family planning agencies providing implant services report that parental consent must be obtained prior to implant insertion.
The Medicaid program has paid for a majority of implant insertions at family planning agencies.
Teenagers who rely on publicly funded family planning clinics for contraceptive services face a variety of barriers in obtaining Norplant.
High method cost, parental consent requirements and issues related to Medicaid eligibility are likely to deter some teenagers who might otherwise choose Norplant.
Mots-clés Pascal : Contraceptif, Lévonorgestrel, Progestatif, Voie souscutanée, Implant, Comportement, Service santé, Conseil clinique, Planning familial, Politique sanitaire, Etats Unis, Amérique du Nord, Amérique, Adolescent, Homme, Femelle
Mots-clés Pascal anglais : Contraceptive, Progestagen, Subcutaneous administration, Implant, Behavior, Health service, Clinical counseling, Family planning, Health policy, United States, North America, America, Adolescent, Human, Female
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0410522
Code Inist : 002A26N02. Création : 01/03/1996.